Bioventus Inc. - COM CL A (BVS)

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM CL A
Shares, excl. options Q3 2024
44.9M
Holdings value Q3 2024
$537M
Value change Q3 2024
+$77.6M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
137
Number of buys Q3 2024
90
Number of sells Q3 2024
-37
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 44.9M $537M +$77.6M $11.95 138
2024 Q2 38.6M $222M +$26.6M $5.75 100
2024 Q1 34.2M $178M +$4.78M $5.20 83
2023 Q4 33.3M $175M +$2.51M $5.27 80
2023 Q3 33M $109M +$3.6M $3.30 67
2023 Q2 31.9M $92.2M +$3.24M $2.89 64
2023 Q1 31.3M $33.6M -$4.75M $1.07 71
2022 Q4 31.4M $81.9M -$22.3M $2.61 83
2022 Q3 35M $245M +$7.46M $7.00 93
2022 Q2 34M $232M +$12.6M $6.82 93
2022 Q1 31.7M $447M +$7.05M $14.10 100
2021 Q4 31.2M $452M +$89.8M $14.49 94
2021 Q3 24.8M $352M +$55.5M $14.16 66
2021 Q2 20.7M $364M -$15.2M $17.60 51
2021 Q1 21.9M $334M +$334M $15.28 45